HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Export notification/recordkeeping requirements

This article was originally published in The Rose Sheet

Executive Summary

FDA extends to July 16 the comment period for the proposed rule outlining notification and recordkeeping requirements to persons exporting cosmetics, OTC and human Rx drugs, biologics, devices, animal drugs and food that may not be marketed or sold in the U.S. The notice appeared in the June 17 Federal Register. The proposed rule was published Nov. 24, 1998



Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts